Patents by Inventor Robert Gurny

Robert Gurny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW SPIRONOLACTONE FORMULATIONS AND THEIR USE
    Publication number: 20210038563
    Abstract: The invention relates to a pharmaceutical formulation comprising a spironolactone and at least one polymer or a polymer mixture as well as its use in particular indications.
    Type: Application
    Filed: January 24, 2019
    Publication date: February 11, 2021
    Inventors: Robert GURNY, Francine BEHAR-COHEN, Jean Louis BOURGES
  • Polylactide compositions and uses thereof
    Patent number: 10314913
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: June 11, 2019
    Assignee: UNIVERSITY OF GENEVA
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • PROTEIN SUSTAINED-RELEASE INJECTABLE FORMULATION
    Publication number: 20180362630
    Abstract: The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). The invention further provides processes for the production of sustained-release pharmaceutical formulations and medical uses thereof.
    Type: Application
    Filed: September 4, 2018
    Publication date: December 20, 2018
    Inventors: Lutz Asmus, Michael Möller, Robert Gurny, P.A. Grimshaw
  • Protein sustained-release injectable formulation
    Patent number: 10093726
    Abstract: The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). The invention further provides processes for the production of sustained-release pharmaceutical formulations and medical uses thereof.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: October 9, 2018
    Assignee: ESBATech, an Alcon Biomedical Research Unit LLC
    Inventors: Lutz Asmus, Michael Möller, Robert Gurny, John P. A. Grimshaw
  • POLYLACTIDE COMPOSITIONS AND USES THEREOF
    Publication number: 20180271984
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Application
    Filed: February 14, 2018
    Publication date: September 27, 2018
    Applicant: UNIVERSITY OF GENEVA
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • Polylactide compositions and uses thereof
    Patent number: 9925267
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: March 27, 2018
    Assignee: University of Geneva
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • Protein sustained-release injectable formulation
    Patent number: 9873736
    Abstract: The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). The invention further provides processes for the production of sustained-release pharmaceutical formulations and medical uses thereof.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: January 23, 2018
    Assignee: ESBATech, an Alcon Biomedical Research Unit LLC
    Inventors: Lutz Asmus, Michael Möller, Robert Gurny, John P. A. Grimshaw
  • Compositions comprising polymers prepared from 2-hydroxyalkyl acids
    Patent number: 9549985
    Abstract: Described herein are compositions comprising polymers prepared by melt polycondensation of 2-hydroxyalkyl acids. Methods of making and using the compositions are also disclosed.
    Type: Grant
    Filed: July 26, 2010
    Date of Patent: January 24, 2017
    Assignee: UNIVERSITE DE GENEVE
    Inventors: Michael Moeller, Lutz Asmus, Robert Gurny
  • POLYLACTIDE COMPOSITIONS AND USES THEREOF
    Publication number: 20160367680
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 22, 2016
    Applicant: UNIVERSITY OF GENEVA
    Inventors: Michael MOLLER, Thomas TRIMAILLE, Robert GURNY
  • PROTEIN SUSTAINED-RELEASE INJECTABLE FORMULATION
    Publication number: 20160362483
    Abstract: The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). The invention further provides processes for the production of sustained-release pharmaceutical formulations and medical uses thereof.
    Type: Application
    Filed: August 24, 2016
    Publication date: December 15, 2016
    Inventors: Lutz Asmus, Michael Möller, Robert Gurny, P.A. Grimshaw
  • Hybrid hydrogels
    Patent number: 9468683
    Abstract: The present invention relates to compositions and pharmaceutical compositions having a hyaluronic acid; a chitosan; and at least one ionic compound in hydrogel form, their use in medical applications and methods of making same as well as medical devices comprising same.
    Type: Grant
    Filed: August 21, 2013
    Date of Patent: October 18, 2016
    Assignee: UNIVERSITY OF GENEVA
    Inventors: Olivier Jordan, Sema Gwendolyn Kaderli, Robert Gurny
  • Polylactide compositions and uses thereof
    Patent number: 9375482
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: June 28, 2016
    Assignee: University of Geneva
    Inventors: Michael Moller, Thomas Trimaille, Robert Gurny
  • HYALURONIC ACID-ANTIOXIDANT CONJUGATES AND THEIR USES
    Publication number: 20150306237
    Abstract: The invention relates to hyaluronic acid (HA) compositions and HA conjugates comprising antioxidant compounds, pharmaceutical compositions thereof and their use in medical applications.
    Type: Application
    Filed: December 18, 2013
    Publication date: October 29, 2015
    Inventors: Robert Gurny, Sema Gwendolyn Kaderli, Leonardo Scapozza, Michael Moeller
  • Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs
    Patent number: 9155745
    Abstract: The present invention is directed to combination formulations of monoclonal antibodies with anti-inflammatory agents, related methods and uses thereof.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: October 13, 2015
    Assignee: UNIVERSITE DE GENEVE
    Inventors: Robert Gurny, Cinzia Stella, Cyrus Tabatabay, Marieke Veurink, Constantin Pournaras
  • HYBRID HYDROGELS
    Publication number: 20150202295
    Abstract: The present invention relates to compositions and pharmaceutical compositions forming hydrogels, their use in medical applications and methods of making same as well as medical devices comprising same.
    Type: Application
    Filed: August 21, 2013
    Publication date: July 23, 2015
    Inventors: Olivier Jordan, Sema G. Kaderli, Robert Gurny
  • Product for use in agriculture or horticulture
    Patent number: 9055722
    Abstract: The invention relates to a product for use in agriculture or horticulture comprising a capsule dissolving or disintegrating in the presence of humidity wherein at least a seed and a controlled release system comprising an agrochemical compound is located.
    Type: Grant
    Filed: November 22, 2002
    Date of Patent: June 16, 2015
    Assignee: Syngenta Crop Protection, Inc.
    Inventors: Diane Zimmermann, Nathalie Nurdin, Eric Allemann, Eric Doelker, Robert Gurny, Eric van der Drift, Ruud Scheffer, Stefan Baum
  • POLYLACTIDE COMPOSITIONS AND USES THEREOF
    Publication number: 20150073060
    Abstract: The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an organic solvent is not required.
    Type: Application
    Filed: April 22, 2014
    Publication date: March 12, 2015
    Applicant: UNIVERSITY OF GENEVA
    Inventors: Michael MOLLER, Thomas TRIMAILLE, Robert GURNY
  • PROTEIN SUSTAINED-RELEASE INJECTABLE FORMULATION
    Publication number: 20150044213
    Abstract: The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). The invention further provides processes for the production of sustained-release pharmaceutical formulations and medical uses thereof.
    Type: Application
    Filed: August 18, 2014
    Publication date: February 12, 2015
    Inventors: Lutz Asmus, Michael Möller, Robert Gurny, John P.A. Grimshaw
  • Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same
    Patent number: 8945609
    Abstract: The aqueous thermosetting neutralized chitosan composition, forming a phosphate-free transparent hydrogel at a temperature higher than 5° C., comprises 0.1 to 5.0 w/w %, based on the total composition, of a reacetylated chitosan having a molecular weight of not smaller than 100 kDa and a deacetylation degree of 40 to 70%, neutralized with an hydroxylated base, and 1 to 30 w/w %, based on the total composition, of a complexing agent selected from polyoses and polyols derived from polyoses. Said composition is useful for the preparation of an injectable formulation.
    Type: Grant
    Filed: December 23, 2005
    Date of Patent: February 3, 2015
    Assignee: Laboratoire Medidom S.A.
    Inventors: Yannic Schuetz, Virginie Caratti-Besson, Oliver Jordan, Robert Gurny
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20140335135
    Abstract: Sustained release formulations of triptorelin are provided.
    Type: Application
    Filed: December 5, 2012
    Publication date: November 13, 2014
    Applicant: FERRING BV
    Inventors: Michael Moller, Robert Gurny, Asmus Lutz, Gregoire Schwach